G71.11 Myotonic muscular dystrophy

Name of the Condition

• Myotonic muscular dystrophy

Summary

Myotonic muscular dystrophy is a genetic disorder characterized by progressive muscle weakness, myotonia (delayed muscle relaxation), and systemic manifestations. It is the most common adult-onset muscular dystrophy, with symptoms affecting multiple organ systems beyond skeletal muscle. The condition typically presents with muscle stiffness, weakness, and associated complications such as cardiac conduction defects or cataracts.

Causes

Myotonic muscular dystrophy is caused by genetic mutations in the DMPK (type 1) or CNBP (type 2) genes, which disrupt normal muscle function and cellular processes. These mutations lead to abnormal RNA processing and protein dysfunction, resulting in progressive muscle degeneration and myotonia. The condition is inherited in an autosomal dominant pattern, meaning a single mutated copy of the gene can cause the disorder.

Risk Factors

• Family history of myotonic muscular dystrophy.
• Inherited autosomal dominant genetic mutation.
• Advanced age (symptoms may worsen over time).

Symptoms

• Delayed muscle relaxation (myotonia) after contraction.
• Progressive muscle weakness, particularly in the face, neck, and distal limbs.
• Muscle wasting (atrophy) and stiffness.
• Cataracts (common in adults).
• Cardiac conduction abnormalities or arrhythmias.
• Respiratory insufficiency in advanced stages.
• Gastrointestinal issues (e.g., dysphagia, constipation).
• Endocrine abnormalities (e.g., insulin resistance, testicular atrophy).

Diagnosis

Diagnosis involves clinical evaluation of muscle stiffness, weakness, and systemic symptoms, supported by specialized tests. Electromyography (EMG) confirms myotonia by demonstrating abnormal muscle electrical activity. Genetic testing identifies mutations in the DMPK or CNBP genes. Additional assessments, such as cardiac monitoring or cataract screening, may be performed to evaluate systemic involvement.

Treatment Options

Treatment focuses on managing symptoms and preventing complications. Physical therapy and assistive devices help maintain mobility and strength. Medications like mexiletine may reduce myotonia. Cardiac monitoring and pacemaker implantation address arrhythmias. Regular screening for respiratory function and cataracts guides preventive care. Multidisciplinary management, including neurology, cardiology, and pulmonology, is often necessary.

Prognosis and Follow-Up

Prognosis varies by severity and age of onset, with gradual progression over decades. Early intervention can improve quality of life, but complications like respiratory failure or cardiac issues may shorten lifespan. Regular follow-up with specialists (e.g., neurologists, cardiologists) is essential to monitor organ involvement and adjust care plans as symptoms evolve.

Complications

• Progressive muscle weakness leading to mobility impairment.
• Cardiac conduction defects or sudden cardiac death.
• Respiratory failure due to weakened respiratory muscles.
• Cataracts and visual impairment.
• Gastrointestinal dysmotility or swallowing difficulties.
• Endocrine disorders (e.g., diabetes, hypogonadism).

Lifestyle & Prevention

While genetic, lifestyle measures can mitigate symptoms. Regular exercise (tailored to ability) preserves muscle function. Avoiding triggers like cold or stress reduces myotonia. Smoking cessation and vaccinations (e.g., flu, pneumonia) protect respiratory health. Genetic counseling is recommended for family planning.

When to Seek Professional Help

Seek care if experiencing persistent muscle stiffness, unexplained weakness, or difficulty with daily activities. Prompt evaluation is needed for symptoms like chest pain, shortness of breath, or fainting (possible cardiac issues) or sudden vision changes (cataracts). Early diagnosis supports timely management of complications.

Tips for Medical Coders

Document the presence of myotonia, muscle weakness, and systemic manifestations (e.g., cardiac, ocular) to support coding. Specify if type 1 or 2 is documented, as this may impact specificity. Include details of genetic testing or family history if available, as these confirm the diagnosis. Ensure documentation aligns with clinical findings to justify the G71.11 code.